Navigation Links
Myriad's Prolaris significantly modifies treatment decisions for prostate cancer patients
Date:1/29/2014

e accurately tells me if a patient has an aggressive prostate cancer or not and guides my treatment decisions," said Ashok Kar, M.D., St. Joseph's Hospital in Orange, Calif. "As a practicing physician, I must ask the same question for every patient; should I use surgery or radiation, or should I use active surveillance and watchful waiting? Prolaris helps me answer this critical clinical question."


'/>"/>

Contact: Ronald Rogers
rrogers@myriad.com
801-584-3065
Myriad Genetics, Inc.
Source:Eurekalert

Page: 1 2

Related biology news :

1. Targeted treatment can significantly reduce relapse in children with AML leukemia
2. Children are significantly more likely to develop PTSD if the mother is already afflicted
3. Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients
4. Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels
5. Synthetic biology research community grows significantly
6. Resistant starch content of potatoes varies significantly by preparation and service method
7. Ceramic indoor cookstove use did not significantly lower child pneumonia risk in rural Kenya
8. Chernobyl cleanup workers had significantly increased risk of leukemia
9. New study: Snacking on raisins significantly reduces overall post-meal blood sugar levels
10. Wistar scientists decipher structure of NatA, an enzyme complex that modifies most human proteins
11. Promising class of antibiotics discovered for treatment of drug-resistant tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... , August 26, 2015 The ... and Five Factor), Application (Travel & Immigration, Government, Banking, ... Global Forecast to 2020", published by MarketsandMarkets, Multi-Factor Authentication ... 2020, growing at a CAGR of 17.7% between 2015 ... 82 F igures spread through 169 ...
(Date:8/20/2015)... The wearable technology market has traditionally ... healthy. However, wearable technology has the potential to ... improve diagnostic capabilities and therapeutic outcomes. Today, Leaf ... Technologies Conference 2015 , where Barrett Larson ... healthcare.    "Over the past decade, ...
(Date:8/18/2015)... N.J. , Aug. 18, 2015 /PRNewswire/ ... a key contributor to the Submission Content ... by IRISS, a non-profit forum. Dedicated to the ... provides a neutral platform for industry, vendors, ... share information and work towards a standard ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... from North Carolina State University, Sandia National Laboratories, and ... technology that uses microneedles to allow doctors to detect ... continuously do so for an extended period of time. ... electrochemical sensors that can be used to detect specific ...
... , Throughout the interior spaces of humans and other warm-blooded ... fat, which may hold the secret to diets and weight-loss ... which the body stores excess calories, brown fat can burn ... things that helps keep wild critters warm on cold nights. ...
... and scrawny "limbs" of the African lungfish would appear to ... walking behavior, newly described by University of Chicago scientists, redraws ... land. Extensive video analysis, published in the ... the African lungfish can use its thin pelvic limbs to ...
Cached Biology News:Microneedle sensors may allow real-time monitoring of body chemistry 2Immunity against the cold 2Immunity against the cold 3A small step for lungfish, a big step for the evolution of walking 2A small step for lungfish, a big step for the evolution of walking 3
(Date:8/31/2015)... 2015 MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) ... Company,s lead antibody, HuMab 5B1, will be garnering major ... the upcoming World Molecular Imaging Congress (WMIC) being held ... Researchers from the Department of Radiology at Memorial Sloan ... use of MabVax,s lead antibody as a PET imaging ...
(Date:8/31/2015)... people with Down syndrome, news from Elixirgen, LLC ... in the Science + Technology Park at Johns Hopkins, ... for people with Down syndrome and other chromosome disorders in ... Edwards syndrome aneuploidies in human cell cultures, " published ... to develop this technology into a treatment for the ...
(Date:8/31/2015)... 31, 2015 FLX Bio, Inc., a biopharmaceutical ... cancer immunotherapies, announced today that it has appointed ... and William Ho , M.D., Ph.D., as Chief ... management team led by veterans of Flexus Biosciences, Inc., ... Scientific Officer; Jay Powers , Ph.D., Vice President, ...
(Date:8/31/2015)... ... 31, 2015 , ... There’s a new treatment option for excessive menstrual bleeding ... new FDA approved system in the last 14 years, and the only endometrial ablation ... bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and the fastest ...
Breaking Biology Technology:MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 3MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 4New Down syndrome therapy discovered 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3
... Combining database and personalized print technology, a physicians group ... house call to retain patients. Instead of waiting for ... physicians are sending personalized messages by mail with reminders ... rates of 10 to 21 percent. , ,The physicians ...
... Delta Dental Plan of Wisconsin and Delta Dental Plan ... the previous investments made by Aetna, Ameritas Life Insurance ... Insurance Company of America, MetLife and Dental Benefit Providers ... have joined together in a cooperative technology venture to ...
... Demo 2003 conference offered a reality check and insights ... sessions focused on products in the search, productivity, security, ... are leading technologists discussed how the prospect of a ... Networks, Open Source and Web Bloggers. They were upbeat ...
Cached Biology Technology:CPM Helps Physicians Group Retain Patients with New Kind of House Call 2Industry Veterans discuss the "next big thing" 2Industry Veterans discuss the "next big thing" 3
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
Monoclonal antibodies conjugated with rhodamine...
... is a trademark of Merck KGaA. Physical form: Solution ... 8.0, 2 mM MgCl 2 , and 20 mM ... herring sperm DNA to acid-soluble oligonucleotides equivalent to a ... pH 8.0 at 37 C (reaction volume 2.625 ml). ...
Biology Products: